0002157566-26-000001.txt : 20261002 0002157566-26-000001.hdr.sgml : 20261002 20261001215402 ACCESSION NUMBER: 0002157566-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261002 DATE AS OF CHANGE: 20261001 EFFECTIVENESS DATE: 20261002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CAD Therapeutics, Inc. CENTRAL INDEX KEY: 0002157566 ORGANIZATION NAME: EIN: 852311823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-599718 FILM NUMBER: 261433324 BUSINESS ADDRESS: STREET 1: 6 ST JOHNS LN CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: 6464567684 MAIL ADDRESS: STREET 1: 6 ST JOHNS LN CITY: NEW YORK STATE: NY ZIP: 10013 D 1 primary_doc.xml X0708 D LIVE 0002157566 CAD Therapeutics, Inc. 6 ST JOHNS LN NEW YORK NY NEW YORK 10013 6464567684 DELAWARE None None Corporation true CHRISTOPHER TEAS 6 ST. JOHNS LN NEW YORK NY NEW YORK 10013 Executive Officer PRESIDENT SORINA BURI 6 ST JOHNS LN NEW YORK NY NEW YORK 10013 Director Biotechnology No Revenues 06b false 2026-09-17 false true true SERIES A COMMON STOCK false 0 10000000 4000000 6000000 false 2 0 0 0 false CAD Therapeutics, Inc. CHRISTOPHER TEAS CHRISTOPHER TEAS PRESIDENT 2026-10-01